Test Price
3,000 AEDโ Home Collection Available
Clinical Exome Trio Sequencing in UAE | 7,500 AED | DHA-Approved Genetic Analysis
Executive Summary & Core Metrics
Diagnostic Accuracy: 99.9% sensitivity via ISO 9001:2015 certified NGS workflow with ACMG variant classification standards.
Logistics Excellence: VIP mobile phlebotomy and temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM across all UAE emirates.
Clinical Guidance: Pre- and post-test genetic counselling by DHA-licensed Consultant Medical Geneticist with tele-health interpretation sessions.
Insurance Support: Direct billing verification via WhatsApp +971 54 548 8731 with coverage confirmation within 2 business hours.
Test Overview & Methodology
Clinical Exome Trio Sequencing simultaneously analyses the entire coding regions (exomes) of a child and both biological parents to identify pathogenic variants causing rare genetic disorders. This test leverages next-generation sequencing (NGS) with 99.9% diagnostic sensitivity, delivering results within 21 business days under DHA-certified genetic counselling. The trio design enables phased inheritance analysis, reducing variant of uncertain significance (VUS) rates by up to 40% compared to proband-only sequencing.
| Feature | Our Test (Trio Whole Exome) | Closest Alternative (Proband-Only) |
|---|---|---|
| Precision | 99.9% NGS coverage โ ACMG variant classification with parental segregation | ~95% โ higher VUS rate, parental variants missed without add-on |
| Method | Trio-simultaneous WES with phased inheritance analysis and CNV detection | Singleton exome, retrospective trio add-on requiring separate consent |
| Speed | 21 business days, ISO-cold-chain home collection included | 28+ business days, standard lab drop-off only |
Physician Insight & Safety Protocols
โClinical exome trio sequencing represents the gold standard for diagnosing neurodevelopmental disorders, congenital anomalies, and suspected monogenic conditions in paediatric populations. The trio design dramatically improves diagnostic yield by enabling real-time segregation analysis. However, every variant must be interpreted within the full clinical context, and secondary findings are managed according to ACMG recommendations. Our integrated counselling pathway ensures families understand implications before and after testing.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Medication Advisory
Do not discontinue or alter any prescribed medication based on genetic results without explicit consultation with your treating physician. Genetic findings may influence therapeutic decisions only under direct medical supervision with appropriate pharmacogenomic expertise.
Exclusion Criteria & Emergency Guidance
- Recent bone marrow or stem cell transplant (chimerism may invalidate germline results)
- Severe anaemia (Hb < 7 g/dL) โ risk of insufficient DNA yield from blood draw
- Active systemic infection requiring intensive care admission
- Emergency Red Flags: If you experience acute neurological deterioration, severe bleeding, or pregnancy-related complications, proceed to the nearest emergency department immediately. This test is elective and not intended for acute diagnostic workup.
Patient FAQ & Clinical Guidance
1. What is clinical exome trio sequencing and why is it recommended for my child?
Clinical exome trio sequencing is a comprehensive genetic test that compares DNA from the child and both biological parents to identify disease-causing mutations with 99.9% accuracy. It is recommended when a rare genetic disorder is suspected based on clinical features, developmental delays, congenital anomalies, or family history, as the trio design maximises diagnostic yield and reduces uncertain results.
2. How long does the testing process take and what does it involve?
Results are delivered within 21 business days via a secure online portal. The process includes a pre-test genetic counselling session, sample collection via VIP mobile phlebotomy at your home or at our Dubai Healthcare City facility, and a post-test counselling session to explain results, inheritance patterns, and clinical recommendations.
3. Is my genetic data protected under UAE privacy laws?
Yes. Your genetic data is encrypted end-to-end and protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Data is never shared with third parties without explicit written consent, and all storage complies with DHA information security standards.
4. Can I use insurance to cover the cost of this test?
Yes. DNA Labs UAE is an in-network provider with major UAE insurance carriers. We recommend sending your insurance card via WhatsApp to +971 54 548 8731 for a coverage verification and pre-authorisation request within two business hours.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance Framework
DNA Labs UAE operates under DHA Facility License No. 1143 and adheres to all applicable UAE federal health data protection regulations. Patient genetic information is processed, stored, and transmitted in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical genetic testing safety and patient consent protocols follow Federal Decree-Law No. 4 of 2016 on Medical Liability. All counselling services are delivered by DHA-licensed genetic specialists.
ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139) | 24/7 WhatsApp Support: +971 54 548 8731
Clinical & Logistical Metadata
| Test Name | Clinical Exome Trio Sequencing |
| Price (AED) | 7,500 |
| Turnaround Time | 21 Business Days |
| Sample Type / Matrix | Peripheral Whole Blood (3โ5 mL per participant in EDTA tubes) or Saliva (Oragene OG-500 kit). VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM. |
| Methodology Used | Next-Generation Sequencing (NGS) โ Whole Exome Sequencing with Trio-Phase Inheritance Analysis and CNV detection |
| ICD-10-CM Code | Z13.71, Z13.79, R89.8 |
| LOINC Code | 94041-0 |
| DHA Facility License & Laboratory Address | DHA Facility License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians